Corvus Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Corvus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$5.94M, a 5.57% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$23.4M, a 22.9% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$23.4M, a 28.1% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$32.6M, a 15.7% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$38.6M, a 11.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$23.4M +$9.16M +28.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$32.6M +$6.07M +15.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$38.6M +$5.13M +11.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 -$43.8M +$5.09M +10.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 -$48.9M +$368K +0.75% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 -$49.2M +$7.3M +12.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 -$56.5M -$19.5M -52.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 -$37M -$23.2M -169% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 -$13.8M -$13.6M -8453% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$161K Jan 27, 2014 Dec 31, 2014 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.